Dpd. Woldbye et al., NEUROPEPTIDE-Y ATTENUATES NALOXONE-PRECIPITATED MORPHINE-WITHDRAWAL VIA Y5-LIKE RECEPTORS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 633-636
The effects of intracerebroventricular injection of neuropeptide Y (NP
Y) and various NPY-related peptides were studied on naloxone-precipita
ted withdrawal from morphine in rats. The withdrawal reaction was asse
ssed using an overall motor score, including jumping, wet dog shakes a
nd other motor-related signs as well as a nonmotor score. At doses of
3, 6 or 12 nmol, NPY strongly and dose-dependently reduced the motor s
core. A less prominent inhibitory effect was revealed on the nonmotor
score. At 6 nmol, [Leu31,Pro34]-NPY, NPY 3-36, peptide YY and human pa
ncreatic polypeptide all significantly attenuated the motor score, whe
reas NPY 13-36 was without effect. This pharmacological profile sugges
ts that the antiwithdrawal effect of NPY is mediated via the recently
cloned Y5 receptor. Our data are consistent with a potential role for
NPY and Y5-like receptors in basic mechanisms and as a therapeutic tar
get in opioid dependence and withdrawal.